Mr. Harton has joined BlueGnome from Reprogenetics, where he was the head of Molecular Genetics, Research & Development and also acted on the Business Development team. Prior to Reprogenetics, Mr. Harton served in various roles including both Laboratory and Management over 22 years at Genetics & IVF Institute.
Mr Harton is a well-respected member of the IVF and PGD community and has been an author of over 40 peer-reviewed scientific articles and abstracts. Mr Harton is certified by the American Board of Bioanalysis (ABB) as a Technical Supervisor, Molecular Diagnostics, and is a member of the American Society for Reproductive Medicine (ASRM), European Society of Human Reproduction and Embryology (ESHRE), Preimplantation Genetic Diagnosis International Society, and member of the College of American Pathologists Working Group on PGD accreditation.
Mr Harton is currently the Chair of the ESHRE PGD Consortium Steering Committee.
Commenting on this appointment, CEO of BlueGnome, Nick Haan said "We are very pleased that someone of Gary’s stature has decided to join the team here at BlueGnome. Gary, who will be establishing our new office in Washington DC, will strengthen our team in the Americas and further support our US customers. With Gary joining Prof Alan Handyside on our senior team BlueGnome is now uniquely well positioned to exploit the growing opportunity in the application of molecular genetics to improving IVF outcomes."
24sure is marked for research use only and is not for use in diagnostic procedures.
*******
For further information please contact:
Dr. Sally Cartwright
Sally.Cartwright@cambridgebluegnome.com
_______________________________________